• 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine: Elevating Src

  2026-06-19

  PP 3 (1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine) serves as the definitive negative control for Src kinase inhibitor PP 2, enabling precise dissection of cell signaling pathways. This article details experimental workflows, advanced applications, and troubleshooting strategies that harness PP 3's specificity and reliability for research use only chemical assays.

• Catalpol in Ischemic Stroke Models: Protocols and Research I

  2026-06-19

  Catalpol, a potent iridoid glycoside, is redefining neuroprotection and angiogenesis workflows in ischemic stroke and beyond. This article distills best-practice protocols, highlights recent mechanistic advances, and delivers actionable troubleshooting tips for maximizing Catalpol’s efficacy in translational disease models.

• Viral-Induced RIPK3 Degradation Modulates Necroptosis and In

  2026-06-18

  This study identifies a novel class of orthopoxvirus proteins that induce proteasomal degradation of RIPK3, directly suppressing necroptosis and shaping virus-induced inflammation. These findings advance our understanding of viral immune evasion and suggest new mechanistic entry points for studying cell death pathways in infection models.

• MLN4924 and the Dynamic Regulation of CRLs: Beyond Neddylati

  2026-06-18

  Explore MLN4924 as a selective NEDD8-activating enzyme inhibitor and discover advanced insights into its role in dynamic cullin-RING ligase regulation. This article uniquely integrates structural biology findings to guide cancer research applications.

• Dextran Microgel Nanotherapeutics for Targeted Oral Colon Ca

  2026-06-17

  Lu et al. present a multifunctional microfluidized dextran microgel system for the oral delivery of cisplatin and magnetic nanoparticles, offering dual targeting and localized drug release in the colon. This innovation addresses longstanding barriers to effective oral chemotherapy in colorectal cancer, with significant implications for minimizing systemic toxicity and enhancing local tumor control.

• Resiniferatoxin (RTX): Applied Workflows for TRPV1 Inactivat

  2026-06-17

  Harnessing Resiniferatoxin (RTX) empowers researchers to achieve targeted chemical inactivation of TRPV1-positive sensory neurons, enabling precise pain modeling and durable analgesia in preclinical studies. This article provides actionable protocols, troubleshooting strategies, and a translation of cutting-edge findings to optimize the applied use of RTX in pain and inflammation research.

• Wortmannin: Precision PI3K Inhibitor for Advanced Cell Assay

  2026-06-16

  Wortmannin’s selective and irreversible PI3K inhibition empowers researchers to dissect signaling pathways with unprecedented clarity, streamlining apoptosis assays, cancer research, and autophagy models. This guide offers protocol enhancements, troubleshooting, and practical insights to maximize experimental reliability using Wortmannin from APExBIO.

• SP1/ADAM10/DRP1 Axis Regulates Cell Crosstalk in Hypoxic PH

  2026-06-16

  This study elucidates how the SP1/ADAM10/DRP1 axis mediates communication between endothelial and smooth muscle cells under hypoxic pulmonary hypertension. The findings highlight novel mechanisms of vascular remodeling, offering new molecular targets for therapeutic intervention in hypoxia-induced pulmonary hypertension.

• QX77: Elevating Chaperone-Mediated Autophagy for Translation

  2026-06-15

  This article bridges mechanistic insight and translational strategy around QX77, a molecular chaperone activator, providing actionable guidance for researchers targeting autophagy and stem cell differentiation. Drawing on recent advances in disease modeling and cellular pathway analysis, it positions QX77 as an indispensable tool for next-generation autophagy research, moving beyond typical product narratives.

• Hydrocortisone in Applied Inflammation Model Research

  2026-06-15

  Hydrocortisone stands as the gold-standard glucocorticoid hormone for dissecting inflammation, stress response, and neurodegeneration in both cellular and animal research models. This guide delivers actionable protocols, advanced troubleshooting, and contextualizes the latest findings for biomedical workflows requiring precision and reproducibility.

• 2-APB: Precision in Calcium Oscillation and SOCE Inhibition

  2026-06-14

  2-APB (2-aminoethoxydiphenyl borate) is the gold-standard tool for dissecting IP3R-mediated calcium signaling and store-operated calcium entry in both cell culture and animal models. This guide translates new mechanistic insights into actionable protocols and troubleshooting tactics, enabling researchers to maximize clarity in oxidative stress and ischemia-reperfusion studies.

• Nelfinavir Mesylate: Precision HIV-1 Protease Inhibitor & Fe

  2026-06-13

  Explore how Nelfinavir Mesylate, a potent HIV-1 protease inhibitor, uniquely integrates into both HIV research and ferroptosis studies. This article reveals emerging mechanistic insights and advances beyond existing approaches, guiding innovative experimentation.

• IPR-803: Strategic Insights for Translational uPAR Inhibitio

  2026-06-12

  This article explores the mechanistic foundation and translational promise of IPR-803, a competitive urokinase receptor inhibitor, for disrupting tumor invasion and metastasis. It synthesizes the latest biochemical, cellular, and in vivo evidence, provides protocol guidance, and delivers actionable insights for oncology researchers aiming to leverage uPAR targeting. In sharp contrast to conventional product pages, this piece critically evaluates the strategic value of IPR-803 within the rapidly evolving landscape of anti-metastatic research, while directly linking to supporting literature and advanced workflow resources.

• EPI-001: Androgen Receptor N-Terminal Domain Inhibitor Workf

  2026-06-12

  EPI-001 brings a unique edge to prostate and triple-negative breast cancer research by targeting both full-length and splice variant androgen receptor signaling. This article delivers advanced workflows, troubleshooting insight, and practical guidance to maximize the impact of EPI-001 in AR-driven disease models.

• Entecavir (BMS200475): Optimizing HBV Replication Inhibition

  2026-06-11

  Entecavir (BMS200475) stands out as a potent and selective inhibitor for hepatitis B virus (HBV) replication, especially valuable in studies of drug resistance and decompensated liver disease models. This article delivers practical, evidence-based workflows and troubleshooting insights to maximize assay sensitivity and reproducibility using Entecavir sourced from APExBIO.

451 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page